A Phase II Trial of SHR-3045 Injection in Patients With Rheumatoid Arthritis

NCT07233655 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Moderate to Severe Active Rheumatoid Arthritis

Interventions

DRUG: SHR-3045 Injection
DRUG: SHR-3045 Injection Placebo

Sponsor

Guangdong Hengrui Pharmaceutical Co., Ltd